Answers are grounded in this paper and cite their sources.
Intestinal ultrasound (IUS) is a noninvasive, radiation-free tool that is well-tolerated and frequently preferred by children and families. Its ability to provide real-time assessments that facilitate timely decision-making is driving its adoption as an increasingly important monitoring standard in comprehensive pediatric inflammatory bowel disease care. IUS programs follow a common trajectory: begin by identifying and supporting a physician lead, then scale through additional trained physicians, a consultation service, and, where volume supports it, sonographer or hybrid models. Institutional planning should enable this growth while preserving the point-of-care delivery that defines IUS's clinical value. Sustainability requires institutional commitment to equipment, protected time, training (ideally embedded in fellowship), standardized documentation, and a reimbursement strategy. Equipment is attainable, not aspirational: a moderately priced cart-based system is sufficient and should be framed to leadership as essential infrastructure. Centers that adopt IUS with rigorous documentation and join collaborative registries from the outset will be positioned to generate the outcomes data needed to further advance the field.
No takes yet. Share an insight, caveat, or question.
Spencer et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: